Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2

dc.contributor.authorRoy, Roshan Kumar
dc.contributor.authorSharma, Uttam
dc.contributor.authorWasson, Mishi Kaushal
dc.contributor.authorJain, Aklank
dc.contributor.authorHassan, Md. Imtaiyaz
dc.contributor.authorPrakash, Hridayesh
dc.date.accessioned2024-01-21T10:44:36Z
dc.date.accessioned2024-08-13T13:21:42Z
dc.date.available2024-01-21T10:44:36Z
dc.date.available2024-08-13T13:21:42Z
dc.date.issued2021-10-01T00:00:00
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.3389/fimmu.2021.763313
dc.identifier.issn16643224
dc.identifier.urihttp://10.2.3.109/handle/32116/3806
dc.identifier.urlhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.763313/full
dc.language.isoen_USen_US
dc.publisherFrontiers Media S.A.en_US
dc.subjectCOVID-19en_US
dc.subjectimmune polarizationen_US
dc.subjectinflammasomeen_US
dc.subjectlncRNAsen_US
dc.subjectmacrophageen_US
dc.subjectMAPKen_US
dc.subjectmiRNAen_US
dc.subjectTLRs (toll-like receptors)en_US
dc.titleMacrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2en_US
dc.title.journalFrontiers in Immunologyen_US
dc.typeArticleen_US
dc.type.accesstypeOpen Accessen_US

Files